- Home
- Publications
- Publication Search
- Publication Details
Title
Post-Genomics and Vaccine Improvement for Leishmania
Authors
Keywords
-
Journal
Frontiers in Microbiology
Volume 7, Issue -, Pages -
Publisher
Frontiers Media SA
Online
2016-04-06
DOI
10.3389/fmicb.2016.00467
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Prediction of T Cell Epitopes from Leishmania major Potentially Excreted/Secreted Proteins Inducing Granzyme B Production
- (2016) Ikbel Naouar et al. PLoS One
- Preclinical safety and tolerability of a repeatedly administered human leishmaniasis DNA vaccine
- (2015) O Riede et al. GENE THERAPY
- Computational elucidation of potential antigenic CTL epitopes in Ebola virus
- (2015) Manas R. Dikhit et al. INFECTION GENETICS AND EVOLUTION
- Skin-resident memory CD4+T cells enhance protection againstLeishmania majorinfection
- (2015) Nelson D. Glennie et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Cutaneous Infection withLeishmania majorMediates Heterologous Protection against Visceral Infection withLeishmania infantum
- (2015) Audrey Romano et al. JOURNAL OF IMMUNOLOGY
- Leishmania tarentolae secreting the sand fly salivary antigen PpSP15 confers protection against Leishmania major infection in a susceptible BALB/c mice model
- (2015) A. Katebi et al. MOLECULAR IMMUNOLOGY
- A sand fly salivary protein vaccine shows efficacy against vector-transmitted cutaneous leishmaniasis in nonhuman primates
- (2015) Fabiano Oliveira et al. Science Translational Medicine
- Immunological comparison of DNA vaccination using two delivery systems against canine leishmaniasis
- (2015) Mehdi Shahbazi et al. VETERINARY PARASITOLOGY
- Evaluation of Live Recombinant Nonpathogenic Leishmania tarentolae Expressing Cysteine Proteinase and A2 Genes as a Candidate Vaccine against Experimental Canine Visceral Leishmaniasis
- (2015) Mehdi Shahbazi et al. PLoS One
- Novel vaccine approaches for protection against intracellular pathogens
- (2014) Kristin L Griffiths et al. CURRENT OPINION IN IMMUNOLOGY
- Tissue Requirements for Establishing Long-Term CD4+ T Cell-Mediated Immunity following Leishmania donovani Infection
- (2014) P. T. Bunn et al. JOURNAL OF IMMUNOLOGY
- From Genome Screening to Creation of Vaccine AgainstTrypanosoma cruziby Use of Immunoinformatics
- (2014) Christian Teh-Poot et al. JOURNAL OF INFECTIOUS DISEASES
- Nanobiotechnologic approach to a promising vaccine prototype for immunisation against leishmaniasis: a fast and effective method to incorporate GPI-anchored proteins ofLeishmania amazonensisinto liposomes
- (2014) Marcelle Carolina Colhone et al. JOURNAL OF MICROENCAPSULATION
- Clustered epitopes within a new poly-epitopic HIV-1 DNA vaccine shows immunogenicity in BALB/c mice
- (2014) Nazli Jafarpour et al. MOLECULAR BIOLOGY REPORTS
- Immunogenicity Evaluation of a Rationally Designed Polytope Construct Encoding HLA-A*0201 Restricted Epitopes Derived from Leishmania major Related Proteins in HLA-A2/DR1 Transgenic Mice: Steps toward Polytope Vaccine
- (2014) Negar Seyed et al. PLoS One
- Using Humans to Make a Human Leishmaniasis Vaccine
- (2014) S. Kamhawi et al. Science Translational Medicine
- Modular Multiantigen T Cell Epitope-Enriched DNA Vaccine Against Human Leishmaniasis
- (2014) S. Das et al. Science Translational Medicine
- Enhanced Protective Efficacy of Nonpathogenic Recombinant Leishmania tarentolae Expressing Cysteine Proteinases Combined with a Sand Fly Salivary Antigen
- (2014) Farnaz Zahedifard et al. PLoS Neglected Tropical Diseases
- CD8+ T cells Are Preferentially Activated during Primary Low Dose Leishmania major Infection but Are Completely Dispensable during Secondary Anti-Leishmania Immunity
- (2014) Ifeoma B. Okwor et al. PLoS Neglected Tropical Diseases
- Combining Cationic Liposomal Delivery with MPL-TDM for Cysteine Protease Cocktail Vaccination against Leishmania donovani : Evidence for Antigen Synergy and Protection
- (2014) Amrita Das et al. PLoS Neglected Tropical Diseases
- Chronic Parasitic Infection Maintains High Frequencies of Short-Lived Ly6C+CD4+ Effector T Cells That Are Required for Protection against Re-infection
- (2014) Nathan C. Peters et al. PLoS Pathogens
- Experimental Validation of Multi-Epitope Peptides Including Promising MHC Class I- and II-Restricted Epitopes of Four Known Leishmania infantum Proteins
- (2014) Maria Agallou et al. Frontiers in Immunology
- Leishmania spp. Proteome Data Sets: A Comprehensive Resource for Vaccine Development to Target Visceral Leishmaniasis
- (2014) Toni Aebischer Frontiers in Immunology
- Live Vaccination Tactics: Possible Approaches for Controlling Visceral Leishmaniasis
- (2014) Noushin Saljoughian et al. Frontiers in Immunology
- Cytolytic Activity of the Human Papillomavirus Type 16 E711-20Epitope-Specific Cytotoxic T Lymphocyte Is Enhanced by Heat Shock Protein 110 inHLA-A*0201Transgenic Mice
- (2013) Zhenzhen Ding et al. Clinical and Vaccine Immunology
- The immunology of Leishmania/HIV co-infection
- (2013) Ifeoma Okwor et al. IMMUNOLOGIC RESEARCH
- Live Attenuated Leishmania donovani p27 Gene Knockout Parasites Are Nonpathogenic and Elicit Long-Term Protective Immunity in BALB/c Mice
- (2013) R. Dey et al. JOURNAL OF IMMUNOLOGY
- CD8 T Cell Exhaustion in Human Visceral Leishmaniasis
- (2013) Shalini Gautam et al. JOURNAL OF INFECTIOUS DISEASES
- CD8+ Granzyme B+–Mediated Tissue Injury vs. CD4+IFNγ+–Mediated Parasite Killing in Human Cutaneous Leishmaniasis
- (2013) Claire da Silva Santos et al. JOURNAL OF INVESTIGATIVE DERMATOLOGY
- Evaluation of immune responses and analysis of the effect of vaccination of the Leishmania major recombinant ribosomal proteins L3 or L5 in two different murine models of cutaneous leishmaniasis
- (2013) Laura Ramírez et al. VACCINE
- Case study for a vaccine against leishmaniasis
- (2013) Jorge Alvar et al. VACCINE
- T-cell epitope vaccine design by immunoinformatics
- (2013) A. Patronov et al. Open Biology
- Development of Novel Prime-Boost Strategies Based on a Tri-Gene Fusion Recombinant L. tarentolae Vaccine against Experimental Murine Visceral Leishmaniasis
- (2013) Noushin Saljoughian et al. PLoS Neglected Tropical Diseases
- Cytotoxic T Cells Mediate Pathology and Metastasis in Cutaneous Leishmaniasis
- (2013) Fernanda O. Novais et al. PLoS Pathogens
- A Reverse Vaccinology Approach for the Identification of Potential Vaccine Candidates from Leishmania spp
- (2012) Lijo John et al. APPLIED BIOCHEMISTRY AND BIOTECHNOLOGY
- An assessment on epitope prediction methods for protozoa genomes
- (2012) Daniela M Resende et al. BMC BIOINFORMATICS
- Reassessment of Immune Correlates in Human Visceral Leishmaniasis as Defined by Cytokine Release in Whole Blood
- (2012) Om Prakash Singh et al. Clinical and Vaccine Immunology
- Universal Cancer Peptide-Based Therapeutic Vaccine Breaks Tolerance against Telomerase and Eradicates Established Tumor
- (2012) M. Dosset et al. CLINICAL CANCER RESEARCH
- Tracking antigen-specific CD4+T cells throughout the course of chronicLeishmania majorinfection in resistant mice
- (2012) Antonio J. Pagán et al. EUROPEAN JOURNAL OF IMMUNOLOGY
- Evaluation of Recombinant Leishmania Polyprotein Plus Glucopyranosyl Lipid A Stable Emulsion Vaccines against Sand Fly-Transmitted Leishmania major in C57BL/6 Mice
- (2012) N. C. Peters et al. JOURNAL OF IMMUNOLOGY
- Immunity to Sand Fly Salivary Protein LJM11 Modulates Host Response to Vector-Transmitted Leishmania Conferring Ulcer-Free Protection
- (2012) Regis Gomes et al. JOURNAL OF INVESTIGATIVE DERMATOLOGY
- Simultaneous immunisation with a Wilms’ Tumour 1 epitope and its ubiquitin fusions results in enhanced cell mediated immunity and tumour rejection in C57BL/6 mice
- (2012) Nasir Saeedi Eslami et al. MOLECULAR IMMUNOLOGY
- Tissue damage and immunity in cutaneous leishmaniasis
- (2012) S. Nylén et al. PARASITE IMMUNOLOGY
- Cationic liposomes containing soluble Leishmania antigens (SLA) plus CpG ODNs induce protection against murine model of leishmaniasis
- (2012) Vahid Heravi Shargh et al. PARASITOLOGY RESEARCH
- Induction of Protective CD4+ T Cell-Mediated Immunity by a Leishmania Peptide Delivered in Recombinant Influenza Viruses
- (2012) Katherine Kedzierska et al. PLoS One
- Leishmaniasis Worldwide and Global Estimates of Its Incidence
- (2012) Jorge Alvar et al. PLoS One
- Peripheral tissue surveillance and residency by memory T cells
- (2012) Thomas Gebhardt et al. TRENDS IN IMMUNOLOGY
- A multistage-polyepitope vaccine protects against Mycobacterium tuberculosis infection in HLA-DR3 transgenic mice
- (2012) Annemieke Geluk et al. VACCINE
- Prediction and identification of mouse cytotoxic T lymphocyte epitopes in Ebola virus glycoproteins
- (2012) Shipo Wu et al. Virology Journal
- Immunogenicity and immune modulatory effects of in silico predictedL. donovanicandidate peptide vaccines
- (2012) Mona E.E. Elfaki et al. Human Vaccines & Immunotherapeutics
- The early interaction of Leishmania with macrophages and dendritic cells and its influence on the host immune response
- (2012) Dong Liu et al. Frontiers in Cellular and Infection Microbiology
- Adjuvants for Leishmania vaccines: from models to clinical application
- (2012) Vanitha S. Raman et al. Frontiers in Immunology
- Predicting peptide binding to Major Histocompatibility Complex molecules
- (2011) Webber W.P. Liao et al. AUTOIMMUNITY REVIEWS
- Design of immunogenic and effective multi-epitope DNA vaccines for melanoma
- (2011) Hyun-Il Cho et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- The Present and Future of Peptide Vaccines for Cancer
- (2011) Craig L. Slingluff CANCER JOURNAL
- KSAC, the First Defined Polyprotein Vaccine Candidate for Visceral Leishmaniasis
- (2011) Yasuyuki Goto et al. Clinical and Vaccine Immunology
- Leishmaniasis chemotherapy—challenges and opportunities
- (2011) S.L. Croft et al. CLINICAL MICROBIOLOGY AND INFECTION
- Leishmaniasis: focus on the design of nanoparticulate vaccine delivery systems
- (2011) Delaram Doroud et al. Expert Review of Vaccines
- Toxoplasma gondii HLA-B*0702-restricted GRA720-28 peptide with adjuvants and a universal helper T cell epitope elicits CD8+ T cells producing interferon-γ and reduces parasite burden in HLA-B*0702 mice
- (2011) Hua Cong et al. HUMAN IMMUNOLOGY
- Genome‑based vaccine development: A short cut for the future
- (2011) Danilo Gomes Moriel et al. Human vaccines & immunotherapeutics
- Vaccines for Leishmaniasis: From proteome to vaccine candidates
- (2011) Juliane Schroeder et al. Human vaccines & immunotherapeutics
- Emerging Vaccine Informatics
- (2011) Yongqun He et al. JOURNAL OF BIOMEDICINE AND BIOTECHNOLOGY
- Delivery of a cocktail DNA vaccine encoding cysteine proteinases type I, II and III with solid lipid nanoparticles potentiate protective immunity against Leishmania major infection
- (2011) Delaram Doroud et al. JOURNAL OF CONTROLLED RELEASE
- Contribution of proteomics of Leishmania spp. to the understanding of differentiation, drug resistance mechanisms, vaccine and drug development
- (2011) Daniel Paape et al. Journal of Proteomics
- A 2020 vision for vaccines against HIV, tuberculosis and malaria
- (2011) Rino Rappuoli et al. NATURE
- Genome sequencing of the lizard parasite Leishmania tarentolae reveals loss of genes associated to the intracellular stage of human pathogenic species
- (2011) Frédéric Raymond et al. NUCLEIC ACIDS RESEARCH
- Cellular vaccination with bone marrow-derived dendritic cells pulsed with a peptide of Leishmania infantum KMP-11 and CpG oligonucleotides induces protection in a murine model of visceral leishmaniasis
- (2011) Maria Agallou et al. VACCINE
- A clinical trial to evaluate the safety and immunogenicity of the LEISH-F1+MPL-SE vaccine for use in the prevention of visceral leishmaniasis
- (2011) Jaya Chakravarty et al. VACCINE
- In Silico Analysis of Six Known Leishmania major Antigens and In Vitro Evaluation of Specific Epitopes Eliciting HLA-A2 Restricted CD8 T Cell Response
- (2011) Negar Seyed et al. PLoS Neglected Tropical Diseases
- Immunoinformatics: an integrated scenario
- (2010) Namrata Tomar et al. IMMUNOLOGY
- Multiple Antigen Peptide Vaccines against Plasmodium falciparum Malaria
- (2010) B. Mahajan et al. INFECTION AND IMMUNITY
- Genome-Based In Silico Identification of New Mycobacterium tuberculosis Antigens Activating Polyfunctional CD8+ T Cells in Human Tuberculosis
- (2010) S. T. Tang et al. JOURNAL OF IMMUNOLOGY
- Rational design based synthetic polyepitope DNA vaccine for eliciting HIV-specific CD8+ T cell responses
- (2010) S.I. Bazhan et al. MOLECULAR IMMUNOLOGY
- A clinical trial to evaluate the safety and immunogenicity of the LEISH-F1+MPL-SE vaccine when used in combination with sodium stibogluconate for the treatment of mucosal leishmaniasis
- (2010) Alejandro Llanos-Cuentas et al. VACCINE
- VennVax, a DNA-prime, peptide-boost multi-T-cell epitope poxvirus vaccine, induces protective immunity against vaccinia infection by T cell response alone
- (2010) Leonard Moise et al. VACCINE
- Correlation of parasitic load with interleukin-4 response in patients with cutaneous leishmaniasis due toLeishmania tropica
- (2009) Rajesh Kumar et al. FEMS IMMUNOLOGY AND MEDICAL MICROBIOLOGY
- Vaccinology in the genome era
- (2009) C. Daniela Rinaudo et al. JOURNAL OF CLINICAL INVESTIGATION
- Ubiquitin Conjugation of Open Reading Frame F DNA Vaccine Leads to Enhanced Cell-Mediated Immune Response and Induces Protection against Both Antimony-Susceptible and -Resistant Strains of Leishmania donovani
- (2009) A. Sharma et al. JOURNAL OF IMMUNOLOGY
- Intracellular Replication-Deficient Leishmania donovani Induces Long Lasting Protective Immunity against Visceral Leishmaniasis
- (2009) A. Selvapandiyan et al. JOURNAL OF IMMUNOLOGY
- Recruitment of CD8+T cells expressing granzyme A is associated with lesion progression in human cutaneous leishmaniasis
- (2009) D. R. FARIA et al. PARASITE IMMUNOLOGY
- Immunogenicity and Efficacy of Single Antigen Gp63, Polytope and PolytopeHSP70 DNA Vaccines against Visceral Leishmaniasis in Experimental Mouse Model
- (2009) Rakhee Sachdeva et al. PLoS One
- Mining the Leishmania genome for novel antigens and vaccine candidates
- (2009) Carla Herrera-Najera et al. PROTEOMICS
- The Key Role of Genomics in Modern Vaccine and Drug Design for Emerging Infectious Diseases
- (2009) Kate L. Seib et al. PLoS Genetics
- B7-H1 Blockade Increases Survival of Dysfunctional CD8+ T Cells and Confers Protection against Leishmania donovani Infections
- (2009) Trupti Joshi et al. PLoS Pathogens
- Vector Transmission of Leishmania Abrogates Vaccine-Induced Protective Immunity
- (2009) Nathan C. Peters et al. PLoS Pathogens
- Computational Analysis of Cysteine Proteases (Clan CA, Family C1) of Leishmania major to Find Potential Epitopic Regions
- (2009) Babak Saffari et al. GENOMICS PROTEOMICS & BIOINFORMATICS
- Live attenuated Leishmania vaccines: a potential strategic alternative
- (2008) Ricardo Silvestre et al. ARCHIVUM IMMUNOLOGIAE ET THERAPIAE EXPERIMENTALIS
- An in silico immunological approach for prediction of CD8+ T cell epitopes of Leishmania major proteins in susceptible BALB/c and resistant C57BL/6 murine models of infection
- (2008) F.Z. Guerfali et al. INFECTION GENETICS AND EVOLUTION
- A rationally designed tyrosine hydroxylase DNA vaccine induces specific antineuroblastoma immunity
- (2008) N. Huebener et al. MOLECULAR CANCER THERAPEUTICS
- First generation leishmaniasis vaccines: A review of field efficacy trials
- (2008) Sassan Noazin et al. VACCINE
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now